Brown Advisory’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $409K | Buy |
1,586
+240
| +18% | +$61.9K | ﹤0.01% | 1069 |
|
|
2025
Q1 | $301K | Sell |
1,346
-216
| -14% | -$48.4K | ﹤0.01% | 1132 |
|
|
2024
Q4 | $357K | Buy |
1,562
+321
| +26% | +$73.4K | ﹤0.01% | 1107 |
|
|
2024
Q3 | $303K | Sell |
1,241
-15
| -1% | -$3.66K | ﹤0.01% | 1108 |
|
|
2024
Q2 | $240K | Sell |
1,256
-67
| -5% | -$12.8K | ﹤0.01% | 1125 |
|
|
2024
Q1 | $262K | Buy |
1,323
+160
| +14% | +$31.7K | ﹤0.01% | 1108 |
|
|
2023
Q4 | $200K | Buy |
+1,163
| New | +$200K | ﹤0.01% | 1163 |
|
|
2023
Q3 | – | Sell |
-1,166
| Closed | -$255K | – | 1222 |
|
|
2023
Q2 | $255K | Sell |
1,166
-12
| -1% | -$2.62K | ﹤0.01% | 1053 |
|
|
2023
Q1 | $258K | Buy |
1,178
+67
| +6% | +$14.7K | ﹤0.01% | 1070 |
|
|
2022
Q4 | $231K | Buy |
1,111
+2
| +0.2% | +$416 | ﹤0.01% | 1089 |
|
|
2022
Q3 | $242K | Buy |
+1,109
| New | +$242K | ﹤0.01% | 1019 |
|
|
2022
Q2 | – | Sell |
-1,040
| Closed | -$252K | – | 1139 |
|
|
2022
Q1 | $252K | Buy |
1,040
+116
| +13% | +$28.1K | ﹤0.01% | 1007 |
|
|
2021
Q4 | $241K | Hold |
924
| – | – | ﹤0.01% | 1117 |
|
|
2021
Q3 | $244K | Buy |
924
+75
| +9% | +$19.8K | ﹤0.01% | 1000 |
|
|
2021
Q2 | $210K | Sell |
849
-569
| -40% | -$141K | ﹤0.01% | 1017 |
|
|
2021
Q1 | $275K | Buy |
1,418
+90
| +7% | +$17.5K | ﹤0.01% | 966 |
|
|
2020
Q4 | $283K | Buy |
+1,328
| New | +$283K | ﹤0.01% | 887 |
|
|
2013
Q3 | – | Sell |
-14,547
| Closed | -$657K | – | 912 |
|
|
2013
Q2 | $657K | Buy |
+14,547
| New | +$657K | ﹤0.01% | 541 |
|